SHPH insider trading
NasdaqCM HealthcareShuttle Pharmaceuticals Holdings, Inc.: insider trade history from SEC Form 4 filings.
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Company website: www.shuttlepharma.com
SHPH insider activity at a glance
FilingIQ tracks 27 insider transactions for SHPH in filings since Dec 30, 2022. The most recent transaction is dated Jul 14, 2026.
Across the full history, 6 open-market purchases
and 17 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SHPH insider trades is 53.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SHPH Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SHPH?
- FilingIQ tracks 27 Form 4 insider transactions for SHPH (Shuttle Pharmaceuticals Holdings, Inc.), covering filings from Dec 30, 2022 onwards. 4 of those are dated within the last 90 days.
- Are SHPH insiders net buyers or net sellers?
- Across the full Form 4 history for SHPH, 6 transactions (22%) were open-market purchases and 17 (63%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SHPH insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is SHPH in?
- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $2.01M.
Methodology & sources
Every SHPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.